Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Kofule Pharmaceutical is a Chinese pharmaceutical company based in Chengdu, Sichuan Province, specializing in the research, development, and manufacturing of a wide range of therapeutic products. Established in 2003, the company has built a strong reputation under its "Kofule" brand, particularly for its respiratory health portfolio, which includes well-known cough and asthma treatments such as compound codeine phosphate oral solutions. Kofule operates modern production facilities that comply with national Good Manufacturing Practice (GMP) standards and maintains a robust distribution network across China. In addition to chemical generics, the company develops and markets traditional Chinese medicine (TCM) formulations targeting cardiovascular, digestive, and gynecological conditions. Its business model integrates the entire pharmaceutical value chain, from R&D and manufacturing to domestic and international sales.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Kofule Pharmaceutical Group.